Key result
Mitral valve repair was associated with a reduced risk of death compared to valve replacement in patients undergoing surgery for mitral regurgitation.
Why the study?
Do preoperative clinical and echocardiographic variables predict 5-year survival in patients undergoing mitral regurgitation surgery?
Cohort (n=298)
Do preoperative clinical and echocardiographic variables predict 5-year survival in patients undergoing mitral regurgitation surgery?
Early surgical intervention for mitral regurgitation before the onset of severe symptoms (NYHA III/IV), particularly when valve repair is feasible, is associated with survival comparable to the general population.
Answers are grounded in this paper and cite their sources.
May support repair preference when feasible; leaves open whether preoperative variables predict survival.
OBJECTIVES: The management of patients with mitral regurgitation (MR) constitutes a challenge due to its heterogeneity in terms of etiology and possible treatment strategies. In the present study, we sought to describe the importance of preoperative echocardiographic and clinical variables in relation to outcome 5 years after surgical treatment of MR. METHODS: The echocardiographic reports (transthoracic) from 298 patients were analyzed and the anatomic lesions were classified into one of three main groups (functional, organic degenerated with hypermobile valve or organic degenerated without hypermobility). 5-year cumulative survival was compared with the expected survival in an age- and gender-matched normal population. Risk functions were determined with a Poisson regression model. RESULTS: Operative mortality was 4.4%, with higher mortality in patients with concomitant coronary artery bypass grafting (CABG) (7.6 vs. 2.2%, P=0.03). Survival after 5 years was 65% in patients with concomitant CABG, compared with the expected 86% (P<0.001), 70 vs. 88% (P<0.001) in patients with preoperative NYHA class III/IV, while survival in patients with NYHA class I/II did not differ from the expected (90 vs. 90%, P=0.56). In patients with a hypermobile valve without CABG, postoperative survival did not differ from the expected (91 vs. 89%, P=0.92). The estimated risk ratio for death, repair versus prosthesis, was 0.57 (95% confidence interval 0.32-1.00, P=0.05). CONCLUSIONS: The present study shows that it is possible, using transthoracic echocardiography and clinical data, to identify patients with an excellent outcome. The adverse effects of severe symptomatology and replacement compared with repair are demonstrated. The findings encourage early intervention before severe symptoms occur, especially if repair is possible.
No takes yet. Share an insight, caveat, or question.
Bech‐Hanssen et al. (2003) conducted a cohort in mitral regurgitation (n=298). Mitral valve repair vs. Mitral valve prosthesis was evaluated on Death (RR 0.57, 95% CI 0.32-1.00, p=0.05). Mitral valve repair was associated with a reduced risk of death compared to valve replacement in patients undergoing surgery for mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: